Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.85%
#4 aPriori aPriori +110.10%
#5 Bedrock Bedrock +74.70%
#6 Cysic Cysic +48.18%
#7 Prom Prom +39.78%
#8 Playnance Playnance +35.10%
#9 COTI COTI +28.56%
#10 Nillion Nillion +23.46%
Coin of the day
Wrapped One Wrapped One
Settings
Language
ENGLISH
Currency
USD
Theme
Orchid Ventures, Inc. Orchid Ventures, Inc.

Orchid Ventures, Inc.

ORVRF
Rank in Stocks #42648
Based in Ladera Ranch, California, Orchid Ventures, Inc. operates within the... Based in Ladera Ranch, California, Orchid Ventures, Inc. operates within the cannabis and CBD industries. The company handles the full scope of cannabis vape product operations, from conceptualization and engineering to production, marketing, and distribution throughout North America. It provides various cannabis vapor devices, such as comprehensive kits and individual cartridges, which are marketed under its Orchid Essentials brand. These offerings reach consumers through a network of approximately 150 dispensaries across California and Oregon. Additionally, Orchid Ventures expands its presence by licensing its proprietary hardware and brand to other authorized manufacturers and distributors.
Share Price
$0.00001
Last synced: 2025-05-19
Market Cap
$524.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Orchid Ventures, Inc. (ORVRF)

Category

Healthcare
P/E ratio for Orchid Ventures, Inc. (ORVRF)
P/E ratio as of 2026 TTM: 0
According to Orchid Ventures, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Orchid Ventures, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 41.61 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.